CarrerasLeaders · Carreras Postdoc Program Empowering Future Leaders to Fight Blood Cancers
Horizon Europe — Marie Skłodowska-Curie Actions
- Duration
- 2023-01-01 → 2028-12-31
- EU contribution
- €2,292,480
- Participants
- 46
- Scheme
- HORIZON-TMA-MSCA-Cofund-P
Lines connect the coordinator with its partners.
Results in brief
Carreras Postdoc Program Empowering Future Leaders to Fight Blood Cancers
The CarrerasLeaders program is an international postdoctoral initiative led by the Josep Carreras Leukaemia Research Institute (IJC), a non-profit biomedical research center specializing in leukemia and other blood cancers. This program addresses a critical need for advanced research training in hematological malignancies by funding a total of 16 outstanding postdoctoral researchers over a three-year period. In its initial phase, 10 researchers were selected through a rigorous evaluation process, with additional rounds planned to reach the full target. The objective is to equip these researchers with the expertise, networks, and innovative skills required to translate cutting-edge discoveries into effective clinical applications. Despite significant advances in understanding blood cancers, major gaps persist in converting fundamental discoveries into effective treatments. CarrerasLeaders bridges these gaps by fostering interdisciplinary research, promoting early scientific advances, and strengthening career development. The program covers the full research and innovation cycle - from deciphering disease biology to developing novel treatments, diagnostic tools, and clinical applications- with a global translational approach that ensures leukemia and lymphoma research has a direct real-world impact. Key broader objectives include: - Enhancing the quality and focus of postdoctoral research training in blood cancers to address pressing societal needs. - Promoting cross-sector and interdisciplinary knowledge transfer. - Empowering emerging researchers to advance their careers within a world-class institution. - Increasing the competitiveness and global reputation of the IJC blood cancers community.
Data: CORDIS, © European Union
Project objective
CarrerasLeaders is a new innovative and international postdoctoral programme, designed by Josep Carreras Leukaemia Research Institute (IJC), an independent, non-profit biomedical research institute that is part of the Government of Catalonia network of Research Centres (CERCA). IJC is the first European institute exclusively devoted to leukaemia and other malignant blood diseases. The aim of the programme is to fund 16 excellent postdoctoral researchers for a period of 36 months. The selection of the fellows is merit-based, founded on peer review in an open and transparent selection procedure. Carrerasleaders is addressed to boost career perspective of researchers from a three-dimensional perspective: leadership, independence, and consolidation.This is a world-wide unique postdoctoral program that covers the entire spectrum of research and innovation in blood cancers and goes from understanding disease biology to the implementation of products and processes in the market and into the clinical practice through the development of a global translational approach. Applicants will have complete freedom of research choice within the scope of blood cancers and will be offer highly attractive working conditions and a healthy, inspiring and creative working environment. CarrerasLeaders is designed based on the following objectives: 1. Training the next generation of scientist leaders to advance on the cure of blood cancers, multiplying each one’s skills sets and networks via targeted Career Development Plans and mentoring.2.Improve the quality of blood cancers postdoctoral research training, more targeted addressed to the researchers and societal needs. 3.Enhanced cooperation and transfer knowledge between sectors and disciplines.4.Enable outstanding junior researchers to develop their research careers to an advanced and more independent level in a leading institution such as IJC. 5.Increase the competitiveness of the IJC blood cancers community
Original text from CORDIS.
Participants
- FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS · BadalonaCoordinatorSpain
- AGENCIA DE GESTIO D'AJUTS UNIVERSITARIS I DE RECERCA · BarcelonaSpain
- AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS · MadridSpain
- ANAXOMICS BIOTECH SL · BarcelonaSpain
- APPLIED NANOPARTICLES SL · BarcelonaSpain
- APPLIED RESEARCH USING OMIC SCIENCES SL · BarcelonaSpain
- Asociación Española Contra el Cáncer · MadridSpain
- CHARITE - UNIVERSITAETSMEDIZIN BERLIN · BerlinGermany
- DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG · HeidelbergGermany
- ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE · LausanneSwitzerland
- EUROPEAN HEMATOLOGY ASSOCIATION · DEN HAAGNetherlands
- FONDAZIONE PER L'ISTITUTO ONCOLOGICO DI RICERCA (IOR) · BELLINZONASwitzerland
- FUNDACAO GIMM - GULBENKIAN INSTITUTE FOR MOLECULAR MEDICINE · LISBOAPortugal
- FUNDACIO INSTITUCIO DELS CENTRES DE RECERCA DE CATALUNYA · BarcelonaSpain
- FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA) · BarcelonaSpain
- FUNDACION CIENTIFICA DE LA ASOCIACIÓN ESPANOLA CONTRA EL CANCER · MadridSpain
- Fundació Internacional Josep Carreras · BarcelonaSpain
- GENOME RESEARCH LIMITED LBG · SAFFRON WALDENUnited Kingdom
- Gavin LucasSpain
- Genome Identification Diagnostics GmbH · StrassbergGermany
- GenomeScan B.V. · LeidenNetherlands
- HUMANITAS MIRASOLE SPA · Rozzano (Mi)Italy
- IBM RESEARCH GMBH · RUESCHLIKONSwitzerland
- IMMAGINA BIOTECHNOLOGY SRL · TrentoItaly
- International Society for Experimental Hematology · ChicagoUnited States
- KITHER BIOTECH SRL · TorinoItaly
- Leadership Sculptor GmbH · Baden-BadenGermany
- MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV · MUNCHENGermany
- MEDIZINISCHE HOCHSCHULE HANNOVER · HannoverGermany
- MESOESTETIC PHARMA GROUP S.L. · ViladecansSpain
- MILTENYI BIOTEC BV & CO KG · Bergisch GladbachGermany
- MLL MUNCHNER LEUKAMIELABOR GMBH · MunchenGermany
- NEW YORK UNIVERSITY · NEW YORKUnited States
- NOVOGENE UK COMPANY LIMITED · LondonUnited Kingdom
- ONECHAIN IMMUNOTHERAPEUTICS S.L. · BarcelonaSpain
- QUIMATRYX SL · San SebastianSpain
- SCIENSEED SL · MADRIDSpain
- SEMMELWEIS EGYETEM · BudapestHungary
- TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK · New YorkUnited States
- UNIVERSIDAD POMPEU FABRA · BarcelonaSpain
- UNIVERSITE LIBRE DE BRUXELLES · Bruxelles / BrusselBelgium
- UNIVERSITETET I OSLO · OsloNorway
- UNIVERSITY OF NEWCASTLE UPON TYNE · Newcastle Upon TyneUnited Kingdom
- UNIVERSITY OF SHARJAH · SharjahUnited Arab Emirates
- USTAV MOLEKULARNI GENETIKY AV CR V.V.I. · Praha 4Czechia
- ZECLINICS SL · SANT FELIU DE LLOBREGATSpain
Links
- View on CORDIS
- DOI: 10.3030/101081347
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5fa1b7660&appId=PPGMS
Data: CORDIS, © European Union